Treatment of age related macular degeneration with beta-carotene
OwnerSteven Baranowitz, Andrew Brooknerinventors
Life of this patent
Estimating the term…
Abstract
According to the present invention, there are provided methods for treating age related macular degeneration in a mammal; for preventing impairment of the vision or for improving impaired vision of a mammal whose eye has drusen; for preventing formation or growth of drusen in the eye of a mammal; and for reducing the number or the size of drusen or for fading drusen without resultant areas of retinal atrophy, without resultant impairment of vision, or without a combination of the foregoing in the eye of a mammal. Beta-carotene in appropriate amounts is administered to the mammal.
Claims19
A method for preventing impairment of the vision or for improving impaired vision of a mammal whose eye has drusen comprising administering to said mammal, a therapeutically effect amount of beta-carotene.
A method for reducing the number or the size of drusen or for fading drusen without resultant areas of retinal atrophy in animal whose eye has drusen, without resultant impairment of vision, or without a combination of the foregoing in the eye of a mammal, said method comprising administering to said mammal, a drusen reducing amount of beta-carotene.
Dependencies are inferred from the claim text.